- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparison of dimethyl fumarate and interferon outcomes in an MS cohort ; volume:22 ; number:1 ; day:11 ; month:7 ; year:2022 ; pages:1-8 ; date:12.2022
BMC neurology ; 22, Heft 1 (11.7.2022), 1-8, 12.2022
- Urheber
-
Sattarnezhad, Neda
Healy, Brian C.
Baharnoori, Moogeh
Diaz-Cruz, Camilo
Stankiewicz, James
Weiner, Howard L.
Chitnis, Tanuja
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12883-022-02761-8
- URN
-
urn:nbn:de:101:1-2022091422490094139698
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sattarnezhad, Neda
- Healy, Brian C.
- Baharnoori, Moogeh
- Diaz-Cruz, Camilo
- Stankiewicz, James
- Weiner, Howard L.
- Chitnis, Tanuja
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice
Immunological predictors of dimethyl fumarate‐induced lymphopenia
COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy
Quantifying the Benefits of Dimethyl Fumarate Over β Interferon and Glatiramer Acetate Therapies on Work Productivity Outcomes in MS Patients
Effects of dimethyl fumarate on neuroprotection and immunomodulation
Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study
Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera® (Dimethyl Fumarate)
Effects of dimethyl fumarate in two animal models of MS
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice
Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation
Dimethyl fumarate alters intracellular calcium handling by redox-mediated pleiotropic effects
Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse
Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice
Immunological predictors of dimethyl fumarate‐induced lymphopenia
COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy
Quantifying the Benefits of Dimethyl Fumarate Over β Interferon and Glatiramer Acetate Therapies on Work Productivity Outcomes in MS Patients
Effects of dimethyl fumarate on neuroprotection and immunomodulation
Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study
Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera® (Dimethyl Fumarate)
Effects of dimethyl fumarate in two animal models of MS
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice
Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation
Dimethyl fumarate alters intracellular calcium handling by redox-mediated pleiotropic effects
Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse
Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice
Immunological predictors of dimethyl fumarate‐induced lymphopenia
COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy
Quantifying the Benefits of Dimethyl Fumarate Over β Interferon and Glatiramer Acetate Therapies on Work Productivity Outcomes in MS Patients
Effects of dimethyl fumarate on neuroprotection and immunomodulation
Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study
Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera® (Dimethyl Fumarate)
Effects of dimethyl fumarate in two animal models of MS
Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice
Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation
Dimethyl fumarate alters intracellular calcium handling by redox-mediated pleiotropic effects